Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma
Source abstract
Abstract
Pancreatic ductal adenocarcinoma (PDAC) exhibits difficult penetration of most drugs, leading to a very poor therapeutic outcome with a quite low five-year survival rate. The foremost reason is the highly-dense extracellular matrix (ECM) with abundant collagen and fibronectin secreted by the activated pancreatic stellate cells (PSCs). Here, we constructed a sono-responsive polymeric perfluorohexane (PFH) nanodroplet to elicit a deep drug penetration in PDAC via the combination of exogenous ultrasonic (US) exposure and endogenous ECM modulation for potent sonodynamic therapy (SDT) of PDAC. Under US exposure, the rapid drug release and deep penetration in PDAC tissues were realized. The released and well penetrated all-trans retinoic acid (ATRA) as an inhibitor of activated PSCs successfully reduced the secretion of ECM components to form a non-dense matrix conducive to drug diffusion. Meanwhile, the sonosensitizer, manganese porphyrin (MnPpIX), was triggered to produce robust reactive oxygen species (ROS) to exert the SDT effect under US exposure. Furthermore, oxygen (O2) delivered by PFH nanodroplets alleviated tumor hypoxia and enhanced the eradication of cancer cells. Overall, the sono-responsive polymeric PFH nanodroplets were successfully developed as an efficient strategy for PDAC therapy. STATEMENT OF SIGNIFICANCE: Pancreatic ductal adenocarcinoma (PDAC) is a representative refractory cancer with a highly dense extracellular matrix (ECM), making it difficult for most drugs to penetrate the nearly impenetrable desmoplastic stroma. Seeking methods for deep drug penetration is an extremely pressing matter for the treatment of PDAC and many other solid tumors. Herein, we designed a fluoroalkane-modified polymer to prepare a sono-responsive polymeric perfluorohexane (PFH) nanodroplet for loading sonosensitizers, and inhibitors of activated PSCs and O2. Under ultrasonic exposure, the nanodroplet elicited deep drug penetration in PDAC via ultrasonic disturbance and stromal remodeling, inducing potent sonodynamic therapy (SDT) of PDAC. By combining exogenous ultrasonic exposure and endogenous ECM modulation, this work successfully alleviated the severe physiological barrier of PDAC and achieved a favourable treatment effect.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Pancreatic and Hepatic Oncology Research · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Cancer Statistics, 2021
2. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis10.1016/S1470-2045(16)00172-8 ↗
3. The role of stromal cancer-associated fibroblasts in pancreatic cancer10.1186/s13045-017-0448-5 ↗
4. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition10.1158/0008-5472.CAN-20-2496 ↗
5. Tumor-stroma interactions in pancreatic ductal adenocarcinoma10.1158/1535-7163.MCT-06-0686 ↗
6. The extracellular matrix and pancreatic cancer: a complex relationship10.3390/cancers10090316 ↗
7. The extracellular matrix in pancreatic cancer: description of a complex network and promising therapeutic options10.3390/cancers13174442 ↗
8. Extracellular matrix and its therapeutic potential for cancer treatment10.1038/s41392-021-00544-0 ↗
9. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis10.1186/s12943-018-0927-5 ↗
10. Pancreatic stellate cells - rising stars in pancreatic pathologies10.33549/physiolres.934783 ↗
11. Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition10.1371/journal.pone.0040434 ↗
12. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer10.1038/bjc.2012.569 ↗
13. Targeting pancreatic stellate cells in cancer10.1016/j.trecan.2019.01.001 ↗
14. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming10.1016/j.actbio.2022.03.050 ↗
15. Cell-penetrating peptides for drug delivery across membrane barriers10.1517/17425247.5.1.105 ↗
16. Tumor-microenvironment-responsive size-shrinkable drug-delivery nanosystems for deepened penetration into tumors10.3389/fmolb.2020.576420 ↗
17. Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy10.1038/s41565-022-01122-3 ↗
18. Recent advances in endogenous and exogenous stimuli-responsive nanocarriers for drug delivery and therapeutics10.1248/cpb.c17-00068 ↗
19. Gold nanocage decorated pH-sensitive micelle for highly effective photothermo-chemotherapy and photoacoustic imaging10.1016/j.actbio.2017.10.018 ↗
20. Enhanced vascular permeability by microbubbles and ultrasound in drug delivery10.1248/bpb.b21-00453 ↗
21. Size-modulable nanoprobe for high-performance ultrasound imaging and drug delivery against cancer10.1021/acsnano.8b00076 ↗
22. Ultrasound-responsive materials for drug/gene delivery10.3389/fphar.2019.01650 ↗
23. Perfluorohexane-cored nanodroplets for stimulations-responsive ultrasonography and O2-potentiated photodynamic therapy10.1016/j.biomaterials.2018.05.019 ↗
24. Sonodynamic therapy, a treatment developing from photodynamic therapy10.1016/j.pdpdt.2017.06.003 ↗
25. Gas-filled protein nanostructures as cavitation nuclei for molecule-specific sonodynamic therapy10.1016/j.actbio.2021.09.010 ↗
26. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics10.1007/s11427-017-9262-x ↗
27. Sonodynamic therapy-assisted immunotherapy: a novel modality for cancer treatment10.1111/cas.13578 ↗
28. Oxygen-sufficient nanoplatform for chemo-sonodynamic therapy of hypoxic tumors10.3389/fchem.2020.00358 ↗
29. Fluorocarbon-driven photosensitizer assembly decodes energy conversion pathway for suppressing breast tumor10.1016/j.nantod.2021.101305 ↗
30. A multimodal therapeutic nanoplatform overcoming tumor hypoxia heterogeneity for improved tumor chemoradiotherapy10.1002/adfm.202204629 ↗
31. Multi-functional liposome: a powerful theranostic nano-platform enhancing photodynamic therapy10.1002/advs.202100876 ↗
32. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development10.1016/j.apsb.2020.01.004 ↗
33. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy10.1002/adma.201701429 ↗
34. Boosting cancer immunotherapy via the convenient A2AR inhibition using a tunable nanocatalyst with light-enhanced activity10.1002/adma.202106967 ↗
35. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization10.1021/la0601455 ↗
36. Oxygen therapeutics: perfluorocarbons and blood substitute safety10.1016/j.ccc.2008.12.007 ↗
37. Perfluorocarbon-loaded and redox-activatable photosensitizing agent with oxygen supply for enhancement of fluorescence/photoacoustic imaging guided tumor photodynamic therapy10.1002/adfm.201806199 ↗
38. Ultrasound-triggered phase-transition cationic nanodroplets for enhanced gene delivery10.1021/acsami.5b02832 ↗
39. Perfluorohexane-loaded polymeric nanovesicles with oxygen supply for enhanced sonodynamic therapy10.1021/acsbiomaterials.0c00407 ↗
40. Fluorinated chitosan to enhance transmucosal delivery of sonosensitizer-conjugated catalase for sonodynamic bladder cancer treatment post-intravesical instillation10.1021/acsnano.9b06689 ↗
41. Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem10.1038/s41467-018-05906-x ↗
42. M2-like tumor-associated macrophage-targeted codelivery of STAT6 inhibitor and IKKβ siRNA Induces M2-to-M1 repolarization for cancer immunotherapy with low immune side effects10.1021/acscentsci.9b01235 ↗
43. A novel theranostic nanoplatform based on Pd@Pt-PEG-Ce6 for enhanced photodynamic therapy by modulating tumor hypoxia microenvironment
44. A light and hypoxia-activated nanodrug for cascade photodynamic-chemo cancer therapy10.1039/D1BM00660F ↗